HEMONTO A/S — Credit Rating and Financial Key Figures
CVR number: 29839395
Skt. Clemens Torv 8 B, 8000 Aarhus C
info@hemonto.com
tel: 87421209
www.hemonto.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 22 238.38 | 26 126.45 | 17 687.88 | 19 365.02 | 19 084.43 |
| Employee benefit expenses | -17 054.54 | -21 110.65 | -17 161.64 | -14 397.67 | -15 490.33 |
| Other operating expenses | -2 008.13 | ||||
| Total depreciation | - 365.90 | - 454.71 | - 147.27 | - 147.27 | |
| EBIT | 4 817.94 | 4 561.09 | 526.24 | 2 811.95 | 3 446.83 |
| Other financial income | 47.03 | 123.11 | 160.30 | 261.29 | 295.99 |
| Other financial expenses | -52.78 | -81.58 | -32.04 | - 200.05 | -8.45 |
| Pre-tax profit | 4 812.19 | 4 602.62 | 654.50 | 2 873.19 | 3 734.36 |
| Income taxes | - 663.78 | - 462.74 | - 218.25 | - 645.17 | - 777.54 |
| Net earnings | 4 148.41 | 4 139.88 | 436.25 | 2 228.01 | 2 956.83 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 2.42 | 18 480.58 | |||
| Intangible assets total | 2.42 | 18 480.58 | |||
| Buildings | 441.80 | 294.53 | 147.27 | ||
| Machinery and equipment | 16.00 | ||||
| Other tangible assets | 17.03 | ||||
| Tangible assets total | 17.03 | 16.00 | 441.80 | 294.53 | 147.27 |
| Other non-current investments | 5 996.52 | ||||
| Other receivables | 661.37 | 685.03 | 502.51 | 527.66 | 608.69 |
| Investments total | 6 657.89 | 685.03 | 502.51 | 527.66 | 608.69 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 821.38 | 675.56 | 3 332.20 | 1 081.85 | 1 741.36 |
| Current amounts owed by group member comp. | 3 396.56 | 4 856.18 | 10 341.90 | 6 298.40 | 6 284.92 |
| Prepayments and accrued income | 286.05 | 145.86 | 403.12 | 536.65 | |
| Current other receivables | 487.40 | 1 106.77 | 552.29 | 488.12 | |
| Current deferred tax assets | 1 181.92 | 536.74 | 8.61 | ||
| Short term receivables total | 4 991.39 | 6 784.37 | 14 856.03 | 8 872.40 | 9 059.66 |
| Cash and bank deposits | 5 888.62 | 23 091.51 | 1 802.12 | 6 064.86 | 3 544.43 |
| Cash and cash equivalents | 5 888.62 | 23 091.51 | 1 802.12 | 6 064.86 | 3 544.43 |
| Balance sheet total (assets) | 17 557.35 | 49 057.49 | 17 602.46 | 15 759.45 | 13 360.05 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 2 500.00 | 2 500.00 | 2 500.00 | 2 500.00 | 2 500.00 |
| Shares repurchased | 5 000.00 | 6 150.00 | |||
| Other reserves | 4 677.29 | 14 414.85 | |||
| Retained earnings | -2 995.49 | -8 584.65 | 1 942.35 | -1 979.63 | |
| Profit of the financial year | 4 148.41 | 4 139.88 | 436.25 | 2 228.01 | 2 956.83 |
| Shareholders equity total | 8 330.20 | 12 470.08 | 2 936.25 | 11 670.37 | 9 627.19 |
| Provisions | 720.22 | 1 291.08 | |||
| Non-current other liabilities | 1 501.01 | 1 446.23 | |||
| Non-current deferred tax liabilities | 689.93 | 714.08 | 736.22 | ||
| Non-current liabilities total | 1 501.01 | 1 446.23 | 689.93 | 714.08 | 736.22 |
| Current loans from credit institutions | 0.69 | 1.61 | |||
| Advances received | 1 050.57 | ||||
| Current trade creditors | 598.93 | 975.92 | 2 067.03 | 1 280.03 | 1 045.50 |
| Current owed to group member | 20 004.93 | 8 856.01 | 11.91 | ||
| Short-term deferred tax liabilities | 249.40 | ||||
| Other non-interest bearing current liabilities | 5 356.41 | 10 508.00 | 2 721.76 | 2 094.97 | 1 688.21 |
| Accruals and deferred income | 2 361.24 | 330.77 | |||
| Current liabilities total | 7 005.92 | 33 850.10 | 13 976.27 | 3 375.00 | 2 996.63 |
| Balance sheet total (liabilities) | 17 557.35 | 49 057.49 | 17 602.46 | 15 759.45 | 13 360.05 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.